SOFTWARE OXECAM Oxehealth’s vital sign monitoring software, the Oxecam, allows normal video cameras to be turned into health monitors. The Oxecam, like Star Trek’s famous ‘Tricorder’, delivers contactless vital sign monitoring from a distance of several metres and in a variety of conditions, even in total darkness. Oxecam is able to monitor subjects as they move around a room and therefore report their vital signs wherever they are, even if they are entirely hidden under the covers.

The software provides clinically validated estimates of vital signs derived from low cost, off-the- shelf digital video cameras. The technology can monitor heart rate, breathing rate and blood oxygenation. Work is underway to extend this to include temperature and blood pressure monitoring.


IN SILENCE According to a recent survey on continence care, more than a million people in the UK may be suffering in silence from an easily preventable condition.

It is estimated that 3.2million people over the age of 65 in the UK suffer from incontinence. In a survey of 800 home-based sufferers and their carers, more than 50% said they experience sore and broken skin, caused by exposure

Oxecam uses the science of photoplethysmography, PPG, to detect heart rate, which is the same science as the finger pulse oximeters used in hospitals. PPG measures minute changes in the colour of skin, known as micro- blushes, caused by the heart pumping blood around the body. It can also determine someone’s breathing rate by measuring movements of the chest and upper thorax.

The first widespread use of Oxecam has occurred in the mental health and police custody arena. Here, Oxecam alerts supervising staff of risks to detainee’s health. In doing so, it is addressing the current pressing need for further support in these areas; only last month it was announced that deaths in mental health facilities had peaked sharply, and the Home Secretary’s independent review into deaths in police custody is ongoing.

Oxecam technology is intended for much wider use: clinically, it has been trialled at kidney and neonatal intensive care units at Oxford

to urine and faeces when wearing incontinence pads. This condition is known as Incontinence Associated Dermatitis (IAD).

IAD is preventable and carers can help by ensuring that those at risk of skin damage adopt a daily skin care routine including use of an effective barrier cream.

Cavilon Barrier Cream, from science- based technology company 3M, has been prescribed and used in hospitals for many years. It acts as both a moisturiser, helping to heal sore skin, and a barrier, preventing further damage.

Research was conducted by 3M in association with the Cystitis and Overactive Bladder Foundation, the largest bladder patient support charity in the UK.

Speaking about the survey Victoria Murray, 3M clinical manager, commented: “Around 45% of the people we surveyed are using creams to treat the symptoms of

- 48 -

University Hospital and interest has been received from organisations spanning home care, elderly and juvenile care, baby monitoring and driver safety.

Oxehealth’s award winning team is continuing to make new innovations and breakthroughs, and is currently working to use PPG to detect blood oxygen levels and blood pressure and thermography to detect core temperature – giving the ability to monitor all five critical vital signs.

IAD, however they may be using all-purpose moisturisers which don’t provide the protection needed to prevent the condition.

“Prevention is key, because when skin breakdown occurs, sufferers are prone to more serious conditions such as pressure ulcers.”

IAD affects many sufferers’ confidence levels, stopping them from participating in everyday activities or even leaving the house.

Victoria added: “With Cavilon Barrier Cream now easily available for home use, and requiring only morning and night application, carers can help improve both physical and psychological well- being of sufferers through a preventative skin care regime.”

Detailed advice for carers and sufferers on the use of Cavilon Barrier Cream and information on ‘where to buy’ is available at:

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56